Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Brands

Dickey case under review by USADA

The United States Anti-Doping Agency is reviewing the positive drug test of cyclist Duane Dickey of Minnetonka, Minn. Dickey tested positive for a combination of drugs, including nandrolone, at last year's Tour of Guatemala. The USADA Anti-Doping Review Board determined that sufficient evidence of doping exists to continue studying Dickey's case. Dickey tested positive for the prohibited substances phentermine, boldenone and nandrolone at the Tour of Guatemala on Oct. 28, 2001. The UCI conducted the test and referred the case to USADA.

Don't miss a moment from Paris-Roubaix and Unbound Gravel, to the Giro d’Italia, Tour de France, Vuelta a España, and everything in between when you join Outside+.

By VeloNews Interactive

The United States Anti-Doping Agency is reviewing the positive drug test of cyclist Duane Dickey of Minnetonka, Minn. Dickey tested positive for a combination of drugs, including nandrolone, at last year’s Tour of Guatemala.

The USADA Anti-Doping Review Board determined that sufficient evidence of doping exists to continue studying Dickey’s case.

Dickey tested positive for the prohibited substances phentermine, boldenone and nandrolone at the Tour of Guatemala on Oct. 28, 2001. The UCI conducted the test and referred the case to USADA.